NCT02348372 Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of Single Oral Doses of GSK1278863A in Healthy Subjects Status COMPLETED Phase PHASE1
NCT02345187 fMRI Study to Investigate Hemodynamic Changes in Brain Resulting From Supplementation of Bacopa Monnieri Extract and Multiple Micronutrient Supplementation. Status COMPLETED Phase NA
NCT02345174 Immuno Positron Emission Tomography Study of GSK2849330 in Subjects With Human Epidermal Growth Factor Receptor 3-Positive Solid Tumors Status COMPLETED Phase PHASE1
NCT02345161 A Comparison Study Between the Fixed Dose Triple Combination of Fluticasone Furoate/ Umeclidinium/ Vilanterol Trifenatate (FF/UMEC/VI) With Budesonide/Formoterol in Subjects With Chronic Obstructive Pulmonary Disease (COPD) Status COMPLETED Phase PHASE3
NCT02342769 Prospective Non-Interventional Observational Study of Use of TRIUMEQ and Corresponding Monitoring Measures in Clinical Practice in Germany Status COMPLETED Phase N/A
NCT02339155 Effect of Raxibacumab on Immunogenicity of Anthrax Vaccine Adsorbed Status COMPLETED Phase PHASE4
NCT02331498 Phase I/II Study of Pazopanib+ Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT02324218 This Study Aims to Determine the Incidence, of Hepatitis B Diagnosis Among Diabetes Mellitus Patients of 0-80 Years of Age Status COMPLETED Phase N/A
NCT02323217 I2PETHV - Imidazoline2 Binding Site in Healthy Volunteers Status COMPLETED Phase EARLY_PHASE1
NCT02323178 A Study of Eltrombopag in Patients With CMML and Thrombocytopenia Status COMPLETED Phase PHASE1/PHASE2
NCT02322671 Relative Bioavailability Study of Two Montelukast Sodium (GW483100) 5 Milligrams (mg) Chewable Tablets and One Reference Montelukast Sodium 5 mg Chewable Tablet in Healthy Adult Subjects Status COMPLETED Phase PHASE1
NCT02319668 Antimicrobial Agent for Reducing Bacteria in Aerosols and Oral Cavity Status COMPLETED Phase PHASE4
NCT02314143 Phase II Biomarker Study Comparing the Combination of BRAF Inhibitor Dabrafenib With MEK Inhibitor Trametinib Versus the Combination After Monotherapy With Dabrafenib or Trametinib Status TERMINATED Phase PHASE2
NCT02311881 A 12-Week Efficacy Study of Paracetamol 1000mg Sustained-release Tablets in Patients With Osteoarthritis Status COMPLETED Phase PHASE3
NCT02302417 Study Assessing Utility of a Clinical Questionnaire to Identify Subjects With Features of Both Asthma and Chronic Obstructive Pulmonary Disease (COPD) Status COMPLETED Phase PHASE2
NCT02302404 A Safety and Tolerability Study of GSK2982772, in Single (in Both Fed and Fasted States) and Repeat Oral Doses in Healthy Male Subjects Status COMPLETED Phase PHASE1
NCT02301975 An Efficacy and Safety Study of Fluticasone Furoate/Vilanterol 100/25 Microgram (mcg) Inhalation Powder, Fluticasone Propionate/Salmeterol 250/50 mcg Inhalation Powder, and Fluticasone Propionate 250 mcg Inhalation Powder in Adults and Adolescents With Persistent Asthma Status COMPLETED Phase PHASE3
NCT02300935 Study of Trametinib and Nab-paclitaxel in Patients With Melanoma Status WITHDRAWN Phase PHASE1